Asahi Kasei

Business Overview Asahi Kasei Microcrystalline Cellulose (MCC) Business Asahi Kasei is a leading manufacturer of microcrystalline cellulose (MCC), continuously developing...

Abstract Background: The compaction of formulation blends is a critical stage in pharmaceutical tablet manufacturing, particularly when drug substances or...

Abstract In recent years, increasing attention has been paid to personalized medicine that can flexibly vary dosage forms, dose, and...

The AAPS Annual Meeting 2025 is happening November 9-12, 2025, at the Henry B. Gonzalez Convention Center in San Antonio,...

Abstract To prevent contamination by nitrosamine drug substance-related impurities (NDSRIs) in solid dosage forms, the modeling of drug nitrosation reactions...

PRESS RELEASE October 8, 2025, Asahi Kasei Corp. - Asahi Kasei, a trusted provider in healthcare materials and technology, announced...

This year CPHI Europe opens its doors in Frankfurt at Messe Frankfurt. From 28th to 30th October you can have...

Abstract The research study provides an insight into different manufacturers' microcrystalline celluloses (MCC) thorough characterization, comprising determination of morphology, PSD,...

This poster was presented at the ECP 2025 in Porto Introduction The agglomeration of fine powders during the twin-screw melt...

Background/Objectives: Mini-tablets are a novel pediatric dosage form designed to mask drug taste and facilitate easier administration. This study aimed...